Work

Postbiotics as emerging therapeutic agents in inflammation-mediated metabolic disorders: Mechanisms, gut microbiota modulation, and clinical potential

Year: 2026
Type: article
Abstract: Metabolic disorders such as obesity, type 2 diabetes mellitus (T2DM), and non-alcoholic fatty liver disease (NAFLD) are rapidly increasing global health concerns closely linked to chronic low-grade inflammation and gut microbiota dysbiosis. Recent advances in microbiome research have highlighted postbiotics—bioactive compounds derived from inactivated microorganisms and their metabolic by-products—as promising therapeutic agents for metabolic disease management. Postbiotics include short-chain fatty acids (SCFAs), microbial cell wall components, enzymes, vitamins, exopolysaccharides, and heat-killed bacterial cells, all of which exhibit immunomodulatory, antioxidant, anti-inflammatory, and metabolic regulatory activities. These compounds enhance intestinal barrier integrity, regulate immune signaling pathways such as TLR4/NF-κB and NLRP3 inflammasome, and improve metabolic homeostasis through modulation of glucose and lipid metabolism. SCFAs, particularly butyrate, acetate, and propionate, play a central role in restoring gut integrity, reducing endotoxemia, and promoting regulatory T-cell differentiation. Preclinical evidence suggests that postbiotics derived from genera such as Lactobacillus, Bifidobacterium, and Akkermansia muciniphila can significantly improve metabolic outcomes by reducing inflammation and enhancing gut–metabolic axis function. Despite promising findings, clinical translation remains limited, and further human studies are required to establish efficacy, safety, and standardized therapeutic protocols. This review provides a comprehensive overview of the classification, mechanisms of action, and therapeutic potential of postbiotics in inflammation-mediated metabolic disorders, highlighting their emerging role as next-generation microbiome-based interventions.
Language: English
Open Access status: hybrid
OpenAlex ID: W7236111113
FWCI:
Cites: 83
Cited by:
Related to: 10